期刊文献+

TH基因修饰NdSCs-D-BMSCs治疗PD大鼠的实验研究 被引量:2

Experimental Study on PD Rats Treated with TH Gene Modification of NdSCs-D-BMSCs
暂未订购
导出
摘要 目的:探讨大鼠酪氨酸羟化酶(tyrosinehydroxylase,TH)修饰的骨髓基质源性神经元样干细胞(neuronoid stem cells derived from bone marrow stem cells NdSCs-D-BMSCs)分别在脑室移植途径及纹状体移植途径下对帕金森病(Parkinson's Disease PD)大鼠的治疗作用。方法:将酶切鉴定后的新构建质粒pEGFP-C2-TH经电穿孔法转染培养第8d NdSCs-D-BMSCs后,观察绿色荧光蛋白及TH的共表达,而后分别注射到PD大鼠模型右侧纹状体及右侧脑室,观察大鼠行为学变化,移植细胞在大鼠脑组织内的迁移,以及高效液相方法检测脑内DA的含量。结果:质粒pEGFP-C2-TH转染NdSCs-D-BMSCs后第5d,绿色荧光蛋白表达59.0%,与TH共表达率为83.5%;移植后10周,纹状体移植组及脑室移植组大鼠症状均显著改善,DA含量较模型对照组显著提高(P<0.01),分别恢复至正常水平46.6%、33.0%,移植细胞可以在PD大鼠脑内存活,并出现远处迁移。结论:TH修饰的大鼠NdSCs-D-BMSCs在纹状体移植及脑室移植途径下均对PD大鼠具有明显的治疗作用,为临床中多种移植途径的选择,特别是经脑室穿刺干细胞移植提供实验依据。 Objective :To investigate the therapeutic effects of tyrosine hydroxylase(TH) transfected neu-ronal stem cells derived from bone marrow stem ceils (NdSCs - D - BMSCs) on Parkinson's disease (PD) through different transplantation protocols, including microinjection into the cerebral ventricles (CV) and the striatum (ST). Methods After identification by enzyme digestion, the constructed plasmid pEGFPC2 -TH was transfected into 8 - day - cultured NdSCs - D - BMSCs by electroporation resulting in the coexpression of green fluorescent protein (GFP) and TH. The TH -transfected cells were injected into either the right ST or CV of PD rats. The changes in locomotor activity of PD rats and the migration of transplanted cells in cerebral tissue were monitored and cerebral DA levels were assayed by high performance liquid chromatography (HPLC). Results Five days after plasmid pEGFP - C2 - TH transfection into NdSCs - D - BMSCs, GFP was expressed in 39.0% of the cells and the rate oi co - expression with TH was 85.3%. len weeks following transplantation, the symptoms of PD rats in both groups were significantly improved and DA levels were re- stored to 46.60/0 in:ST group and 33% in CV group of control. The transferred cells showed exceUent survival rates in PD rat brains and distant migration was observed. Conclusion Both CV and ST transplantation of TH - transfected NDSCs - D - BMSCs has obvious therapeutic effects on PD rats. This study could provide evidence for CV transplantation route selection.
出处 《新疆医学》 2012年第6期21-27,共7页 Xinjiang Medical Journal
关键词 基因治疗 骨髓基质源性神经元样干细胞 帕金森病 大鼠 移植途径 Gene therapy Neuronal stem cells derived from bone marrow stem cells Parkinsong dis-ease Rats Transl31antation route
  • 相关文献

参考文献18

二级参考文献30

  • 1徐强,徐如祥,张世忠,张旺明,王树兴.外源性超氧化物歧化酶对大鼠中脑多巴胺能神经元凋亡的保护作用研究[J].中国组织工程研究与临床康复,2001,10(22):54-55. 被引量:4
  • 2陆建明,周厚广.帕金森病大鼠模型的行为学及神经元形态学评价(英文)[J].中国临床康复,2004,8(16):3180-3182. 被引量:5
  • 3Shu S Y,J Med Coll PLA,1995年,10卷,259页
  • 4Shu S Y,Chin Med J(CE),1992年,105期,102页
  • 5Shu S Y,Chin Med J(CE),1991年,104卷,887页
  • 6Albin R L,Trends Neurosci,1989年,12卷,366页
  • 7Paxinos G, Watson C. The Rat Brain in Stereotatic Coordinates[M].Second Edition. USA: San Diego, Academic Press, 1998.36.
  • 8Ferro MM, Bellissimo MI, Anselmo-Franci JA, et al.Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: Histological, neurochemical, motor and memory alterations[J]. J Neurosci Methods, 2005, 148(1): 78-87.
  • 9Ossowska K, Wardas J, Smialowska M, et al. A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?[J]. Eur J Neurosci, 2005,22(6): 1294-1304.
  • 10Jia RR, Gou YL, Ho LS, et al. Anti-apoptotic activity of Bak Foong Pills and its ingredients on 6-hydroxydopamine-induced neurotoxicity in PCI2 cells[J]. Cell Biol Int, 2005, 29(10): 835-842.

共引文献42

同被引文献43

  • 1Emborg ME, Moirano J, Raschke J, et al. Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF. Neu- robiol Dis, 2009, 36(2) : 303-311.
  • 2Zhuang X, Li X, Redus L, et al. Cognitive Dysfunction Precedes the Onset of Motor Symptoms in the MitoPark Mouse Model of Parkinson ' s Disease. PLoS ONE, 2013 , 8 ( 8 ) : e71341.
  • 3Covy JP, Giasson BI. alpha- Synuclein, leucine- rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease. Neurotoxicology, 2011 , 32 ( 5 ) : 622-629.
  • 4Muramatsu SI, Fujimoto KI, Kato S, et al. A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson ' s Disease. Molecular Therapy, 2010, 18 ( 9 ) : 1731-1735.
  • 5Christine CW, Start PA, Larson PS, et al. Safety and toler- ability of putaminal AADC gene therapy for Parkinson disease. Neurology, 2009, 73(20) : 1662-1669.
  • 6McFarland NR, Lee JS, Hyman BT, et al. Comparison of transduction efficiency of recombinant AAV serotypes 1, 2, 5, and 8 in the rat nigrostriatal system. J Neurochemistry, 2009, 109(3): 838-845.
  • 7Mosley RL, Ohshima-Hosoyama S, Simmons HA, et al. A Monoclonal Antibody-GDNF Fusion Protein Is Not Neuropro- tective and Is Associated with Proliferative Pancreatic Lesions in Parkinsonian Monkeys. PLoS ONE, 2012, 7 (6) : e39036.
  • 8Shi D, Chen G, Lv L, et al. The effect of lentivirus-media- ted TH and GDNF genetic engineering mesenchymal stem cells on Parkinson ' s disease rat model. Neurol Sci, 2010, 32 (1) : 41-51.
  • 9Biju KC, Zhou Q, Li G, et al. Macrophage-mediated GDNF Delivery Protects Against Dopaminergic Neurodegeneration: ATherapeutic Strategy for Parkinson' s Disease. Mol Ther, 2010, 18(8): 1536-1544.
  • 10Herr6n E, Ruiz-Ortega J(1, Aristieta A, et al. In vivo ad- ministration of VEGF- and GDNF-releasing biodegradable pol- ymeric microspheres in a severe lesion model of Parkinson ' s disease. Eur J Pharm Biopharm, 2013, 85 (3) : 1183- 1190.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部